盐酸莫西沙星片治疗慢性阻塞性肺疾病急性加重期门诊患者的临床疗效

目的:评价盐酸莫西沙星片治疗慢性阻塞性肺疾病急性加重期门诊患者的临床疗效。方法:收治慢性阻塞性肺疾病急性加重期患者540例,随机分成盐酸莫西沙星片观察组270例和头孢克肟片对照组270例,观察组疗程5天,对照组疗程7天。结果:盐酸莫西沙星片显著优于对照组的临床治愈率(P<0.01)。结论:盐酸莫西沙星片在治疗慢性阻塞性肺疾病急性加重期门诊患者的治疗中具有较好的治疗效果,且有较好的耐受性、安全性好。

Objective：To evaluate the clinical efficacy and safety of outpatients with acut exacerbations of chronic obstructive pulmonary disease treated with Moxifloxacin Hydrochloride Tablets.Methods：five hundred forty outpatients comed from our hospital with acut exacerbations of chronic obstructive pulmonary disease were choosed in July 2008 to in August 2010,they were assigned to two groups randomly,the Moxifloxacin Hydrochloride Tablets group as the observation group,Cefixime Tablets group as the control group there are 270 cases each other,course of the treatment of the observation group is five days,the control group is seven days.Results：The curable rate of Moxifloxacin Hydrochloride Tablets was more significantly than control group（P〈0.01）.Conclusions：The curative effect of outpatients whit Moxifloxacin Hydrochloride Tablets in acut exacerbations of chronic obstructive pulmonary disease was exact and safety,Moxifloxacin Hydrochloride Tablets are more deserve extending.